121 related articles for article (PubMed ID: 24652995)
1. p57 regulates T-cell development and prevents lymphomagenesis by balancing p53 activity and pre-TCR signaling.
Matsumoto A; Takeishi S; Nakayama KI
Blood; 2014 May; 123(22):3429-39. PubMed ID: 24652995
[TBL] [Abstract][Full Text] [Related]
2. p57(Kip2) regulates T-cell development and lymphoma.
Jayapal SR; Kaldis P
Blood; 2014 May; 123(22):3370-1. PubMed ID: 24876523
[No Abstract] [Full Text] [Related]
3. Deregulation of the p57-E2F1-p53 axis results in nonobstructive hydrocephalus and cerebellar malformation in mice.
Matsumoto A; Susaki E; Onoyama I; Nakayama K; Hoshino M; Nakayama KI
Mol Cell Biol; 2011 Oct; 31(20):4176-92. PubMed ID: 21844226
[TBL] [Abstract][Full Text] [Related]
4. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
5. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
López-Nieva P; Fernández-Navarro P; Vaquero-Lorenzo C; Villa-Morales M; Graña-Castro O; Cobos-Fernández MÁ; López-Lorenzo JL; Llamas P; González-Sanchez L; Sastre I; Pollan M; Malumbres M; Santos J; Fernández-Piqueras J
BMC Cancer; 2018 Apr; 18(1):430. PubMed ID: 29661169
[TBL] [Abstract][Full Text] [Related]
6. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity.
Ma Y; Cress WD
Oncogene; 2007 May; 26(24):3532-40. PubMed ID: 17173074
[TBL] [Abstract][Full Text] [Related]
9. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
10. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF
Oncogene; 2007 Aug; 26(35):5086-97. PubMed ID: 17310987
[TBL] [Abstract][Full Text] [Related]
11. Wip1 phosphatase-deficient mice exhibit defective T cell maturation due to sustained p53 activation.
Schito ML; Demidov ON; Saito S; Ashwell JD; Appella E
J Immunol; 2006 Apr; 176(8):4818-25. PubMed ID: 16585576
[TBL] [Abstract][Full Text] [Related]
12. E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution.
Iglesias-Ara A; Zenarruzabeitia O; Buelta L; Merino J; Zubiaga AM
Cell Death Differ; 2015 Oct; 22(10):1577-89. PubMed ID: 25656653
[TBL] [Abstract][Full Text] [Related]
13. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.
Strzadala L; Miazek A; Matuszyk J; Kisielow P
Int Immunol; 1997 Jan; 9(1):127-38. PubMed ID: 9043954
[TBL] [Abstract][Full Text] [Related]
14. A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis.
Hu MG; Deshpande A; Enos M; Mao D; Hinds EA; Hu GF; Chang R; Guo Z; Dose M; Mao C; Tsichlis PN; Gounari F; Hinds PW
Cancer Res; 2009 Feb; 69(3):810-8. PubMed ID: 19155308
[TBL] [Abstract][Full Text] [Related]
15. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
16. Early thymocyte development is regulated by modulation of E2A protein activity.
Engel I; Johns C; Bain G; Rivera RR; Murre C
J Exp Med; 2001 Sep; 194(6):733-45. PubMed ID: 11560990
[TBL] [Abstract][Full Text] [Related]
17. Pre-TCR signaling and inactivation of p53 induces crucial cell survival pathways in pre-T cells.
Haks MC; Krimpenfort P; van den Brakel JH; Kruisbeek AM
Immunity; 1999 Jul; 11(1):91-101. PubMed ID: 10435582
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
19. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
20. Lymphomagenesis and female-specific lethality in p53-deficient mice occur independently of E2f1.
Wloga EH; Criniti V; Yamasaki L; Bronson RT
Nat Cell Biol; 2004 Jul; 6(7):565-7; author reply 567-8. PubMed ID: 15232580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
